Cooperative Agreement 2546719
- This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
- This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Zebramd Inc. aims to develop an electronic health record (EHR) integrated artificial intelligence system capable of predicting rare diseases in undiagnosed patients and providing evidence-based treatment recommendations for already diagnosed rare disease patients. The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to potentially improve the diagnosis and...
- This National Science Foundation (NSF) Cooperative Agreement award, under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $999,988 in funding to Dasion Corporation to develop a healthcare technology platform that utilizes geometric unified learning. The platform aims to enhance the efficiency and accuracy of healthcare diagnostics and monitoring, particularly for diseases that can be diagnosed and monitored using data sources like voice and EEG. The project...
- Federal Cooperative Agreement Summary Award Details: Iiam Corporation received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 15, 2025, with completion targeted for June 30, 2027. The project will be performed in San Francisco, California. Products and Services: This Small Business Innovation Research (SBIR) Phase II project delivers a Natural Language Processing (NLP)-driven...
- Cooperative Agreement Award Summary Echo Mind AI Corp. received a $1.25 million Cooperative Agreement award dated July 15, 2025, from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to develop artificial intelligence (AI)-enabled ultrasound technology for musculoskeletal (MSK) injury imaging and diagnosis. The project, which extends through June 30, 2027, focuses on creating AI-powered guidance systems that enable novice...
- This $1,000,000 cooperative agreement from the National Science Foundation (NSF) will fund the development of a blockchain ecosystem and artificial intelligence to optimize prior authorization processes in the pharmaceutical industry. Red Oak Strategic LLC will leverage distributed ledger technology to create an encrypted, decentralized patient data sharing network among prescribers, payers, and patients. Smart contracts will automate criteria fulfillment, facilitate machine learning-based...
- Federal Cooperative Agreement Summary Asterion AI Inc. received a $1.25 million Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084), effective August 1, 2025 through July 31, 2027. The awardee will develop and validate an electroencephalogram (EEG)-based software product designed for pre-hospital stroke triage and detection of large vessel occlusion (LVO) strokes. The deliverables include expansion of a...
- The National Science Foundation awarded Neuraltrak, Inc. a $1.25 million cooperative agreement on June 15, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop AI-powered methods for generating high-quality three-dimensional computed tomography images from limited-angle X-ray data acquired by standard mobile surgical imaging systems. The project addresses a clinical gap: conventional mobile X-ray systems produce primarily two-dimensional images because...
- Federal Cooperative Agreement Summary Abstractive Health, Inc. received a $1.25 million Small Business Innovation Research (SBIR) Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2025, through June 30, 2027. The awardee will develop and refine a machine learning-enabled software tool that leverages natural language processing (NLP) to automatically generate clinically relevant...
- This $550,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) will support the development of an artificial intelligence (AI) solution for accurate medical coding to improve healthcare billing. The project, led by St. John's University in New York, aims to overcome limitations of current automated biomedical content annotation systems, such as bias, errors, and lack of adaptability. The AI-driven system...
The National Science Foundation awarded Zebramd Inc. a $1.239701 million Cooperative Agreement on August 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an artificial intelligence-supported clinical decision-making platform for diagnosis and patient management. The platform aggregates multimodal patient data from multiple electronic health record systems through a patient-facing application, deploys backend analytics infrastructure using retrieval-augmented generation models and application programming interfaces drawn from validated medical sources, and delivers EHR-integrated real-time clinical decision support alerts. The system incorporates large language models for medical guideline synthesis and secured data handling with encryption and relational databases. Development includes deployment across multiple healthcare institutions with different EHR systems, expansion of patient app availability, and assessment of platform impacts on diagnoses, referrals, and healthcare utilization patterns. Work is performed in West Hills, California. The period of performance runs through July 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 7/16/26 |